Clover BioPharmaceuticals

Clover raises $230M as COVID-19 vaccine nears phase 3, multivariant prospect gets going
Clover raises $230M as COVID-19 vaccine nears phase 3, multivariant prospect gets going
Fierce Biotech
Clover BioPharmaceuticals
COVID-19
vaccines
clinical trials
Flag link:
Biotech partner drops GlaxoSmithKline’s adjuvant as it moves Covid-19 vaccine into PhII/III, citing ‘manufacturing considerations’
Biotech partner drops GlaxoSmithKline’s adjuvant as it moves Covid-19 vaccine into PhII/III, citing ‘manufacturing considerations’
Endpoints
GSK
vaccines
Clover BioPharmaceuticals
adjuvants
Flag link:
Clover nears pivotal trial of GSK-adjuvanted COVID-19 vaccine
Clover nears pivotal trial of GSK-adjuvanted COVID-19 vaccine
Fierce Biotech
Clover BioPharmaceuticals
clinical trials
COVID-19
vaccines
GSK
Flag link:
Using GSK and Dynavax tech, Clover kick-starts COVID-19 vax trial with data drop in August
Using GSK and Dynavax tech, Clover kick-starts COVID-19 vax trial with data drop in August
Fierce Biotech
GSK
Dynavax
Clover BioPharmaceuticals
vaccines
COVID-19
Flag link:
A Chinese biotech partners with GSK to boost its coronavirus vaccine development
A Chinese biotech partners with GSK to boost its coronavirus vaccine development
Stat
China
GSK
vaccines
coronavirus
Clover BioPharmaceuticals
Flag link:
Clover Initiates Ph I Study of Enbrel Biosimilar in China
Clover Initiates Ph I Study of Enbrel Biosimilar in China
CP Wire
Clover BioPharmaceuticals
Enbrel
Amgen
biosimilars
SCB-808
China
Flag link:
Clover Initiates Ph I Study of Enbrel Biosimilar in China
Clover BioPharmaceuticals
SCB-808
Enbrel
generics
Flag link:
Chinese drugmakers tap GE tech, seeing biologic boom ahead
Chinese drugmakers tap GE tech, seeing biologic boom ahead
Biopharma Dive
China
biologics
GE Healthcare
Clover BioPharmaceuticals
Flag link: